A literature review of cost-benefit analyses for the treatment of alcohol dependence (Q35195707)

7 August 2017

3 references

19 March 2019

30 May 2020

13 July 2020

A literature review of cost-benefit analyses for the treatment of alcohol dependence (English)

1 reference

7 August 2017

2 references

19 March 2019

13 July 2020

5

Jürgen Rehm

1 reference

7 August 2017

Svetlana Popova

1

1 reference

7 August 2017

Satya Mohapatra

series ordinal

2

1 reference

7 August 2017

Jayadeep Patra

series ordinal

3

1 reference

7 August 2017

Amy Duhig

series ordinal

4

1 reference

7 August 2017

language of work or name

1 reference

16 August 2011

1 reference

International Journal of Environmental Research and Public Health

7 August 2017

1 August 2011

3 references

19 March 2019

30 May 2020

13 July 2020

4 references

7 August 2017

19 March 2019

30 May 2020

13 July 2020

8

1 reference

7 August 2017

8

1 reference

7 August 2017

3351-3364

1 reference

Creative Commons Attribution 3.0 Unported

7 August 2017

3 references

19 March 2019

30 May 2020

on focus list of Wikimedia project

13 July 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

Pharmacotherapies for alcoholism: the old and the new.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

Effectiveness and safety of baclofen in the treatment of alcohol dependent patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

What makes group MET work? A randomized controlled trial of college student drinkers in mandated alcohol diversion

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

Medications for treating alcohol dependence

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

Brief physician advice for problem drinking among older adults: an economic analysis of costs and benefits.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

A critical review of pharmacoeconomic studies of acamprosate

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

Development of medications for alcohol use disorders: recent advances and ongoing challenges

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

Alcohol interventions for trauma patients treated in emergency departments and hospitals: a cost benefit analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

Cost benefits of substance abuse treatment: an overview of results from alcohol and drug abuse

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

Brief physician advice for problem drinkers: long-term efficacy and benefit-cost analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

Cost-benefit and cost-effectiveness analyses of behavioral marital therapy as an addition to outpatient alcoholism treatment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

Examining treatment use among alcohol-dependent individuals from a population perspective.

28 July 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJERPH8083351

Treating adolescent drug abuse: a randomized trial comparing multidimensional family therapy and cognitive behavior therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJERPH8083351

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJERPH8083351

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJERPH8083351

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJERPH8083351

The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJERPH8083351

The cost-effectiveness and cost-benefit of screening and brief intervention for unhealthy alcohol use in medical settings

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJERPH8083351

The effect of alcoholism treatment on medical care use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJERPH8083351

Choosing a behavioral therapy platform for pharmacotherapy of substance users

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJERPH8083351

New pharmacotherapies for alcohol dependence.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166747

Benefit-cost analysis of brief physician advice with problem drinkers in primary care settings

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21909311

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Analyzing the costs and benefits of brief intervention.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21909311

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Economic evaluation of Campral (Acamprosate) compared to placebo in maintaining abstinence in alcohol-dependent patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21909311

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3390/IJERPH8083351

1 reference

7 August 2017

1 reference

7 August 2017

1 reference